DK163277C - Anthracyklinglycosid-kardiolipinkompleks indkapslet i liposomer, fremgangsmaade til fremstilling heraf samt terapeutisk praeparat indeholdende dette - Google Patents

Anthracyklinglycosid-kardiolipinkompleks indkapslet i liposomer, fremgangsmaade til fremstilling heraf samt terapeutisk praeparat indeholdende dette

Info

Publication number
DK163277C
DK163277C DK573082A DK573082A DK163277C DK 163277 C DK163277 C DK 163277C DK 573082 A DK573082 A DK 573082A DK 573082 A DK573082 A DK 573082A DK 163277 C DK163277 C DK 163277C
Authority
DK
Denmark
Prior art keywords
anthracycling
cardiolipine
lycoside
liposomes
procedures
Prior art date
Application number
DK573082A
Other languages
Danish (da)
English (en)
Other versions
DK163277B (da
DK573082A (da
Inventor
Aquilur Rahman
Philip S Schein
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of DK573082A publication Critical patent/DK573082A/da
Publication of DK163277B publication Critical patent/DK163277B/da
Application granted granted Critical
Publication of DK163277C publication Critical patent/DK163277C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK573082A 1981-04-27 1982-12-23 Anthracyklinglycosid-kardiolipinkompleks indkapslet i liposomer, fremgangsmaade til fremstilling heraf samt terapeutisk praeparat indeholdende dette DK163277C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/258,016 US4419348A (en) 1981-04-27 1981-04-27 Anthracycline glycoside compositions, their use and preparation
US25801681 1981-04-27
US8200464 1982-04-14
PCT/US1982/000464 WO1982003769A1 (en) 1981-04-27 1982-04-14 Anthracycline glycoside compositions,their use and preparation

Publications (3)

Publication Number Publication Date
DK573082A DK573082A (da) 1982-12-23
DK163277B DK163277B (da) 1992-02-17
DK163277C true DK163277C (da) 1992-07-06

Family

ID=22978743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK573082A DK163277C (da) 1981-04-27 1982-12-23 Anthracyklinglycosid-kardiolipinkompleks indkapslet i liposomer, fremgangsmaade til fremstilling heraf samt terapeutisk praeparat indeholdende dette

Country Status (7)

Country Link
US (1) US4419348A (de)
EP (1) EP0077377B1 (de)
JP (1) JPS58500715A (de)
AU (1) AU552812B2 (de)
DE (1) DE3268367D1 (de)
DK (1) DK163277C (de)
WO (1) WO1982003769A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612370A (en) * 1982-04-02 1986-09-16 The Regents Of The University Of California Lipid-saccharide reaction products
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
US4771130A (en) * 1984-02-17 1988-09-13 William Cohen Target-entrapped drugs
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US5244678A (en) * 1986-01-14 1993-09-14 Ire-Celltarg S.A. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
JPH0825869B2 (ja) * 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
WO1988007852A1 (en) * 1987-04-06 1988-10-20 Innovative Therapeutics Corporation Liposome entrapped magnesium
US4863739A (en) * 1987-05-19 1989-09-05 Board Of Regents, The University Of Texas System Liposome compositions of anthracycline derivatives
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
EP0396626A1 (de) * 1988-01-19 1990-11-14 Board Of Regents, The University Of Texas System Glycoside, sie enthaltende liposome und ihre verwendung
US6060080A (en) * 1990-07-16 2000-05-09 Daiichi Pharmaceutical Co., Ltd. Liposomal products
CA2046997C (en) * 1990-07-16 2000-12-12 Hiroshi Kikuchi Liposomal products
ATE138803T1 (de) * 1990-07-31 1996-06-15 Liposome Co Inc Anhäufung von aminosäuren und peptiden in liposomen
WO1994005259A1 (en) * 1992-09-02 1994-03-17 Georgetown University Method of encapsulating anthracycline glycosides in liposomes
US7314637B1 (en) 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
MXPA03004095A (es) 2000-11-09 2004-09-10 Neopharm Inc Complejos de sn-38 con lipidos y sus metodos de uso.
WO2003030864A1 (en) 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
WO2004069224A2 (en) 2003-02-03 2004-08-19 Neopharm, Inc. Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
WO2015040636A1 (en) * 2013-09-19 2015-03-26 Council Of Scientific & Industrial Research Synergistic liposomal formulation for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
IL55431A (en) * 1978-08-24 1982-07-30 Yeda Res & Dev Anthracycline type antibiotics,their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
JPS58500715A (ja) 1983-05-06
JPH0526767B2 (de) 1993-04-19
EP0077377A4 (de) 1983-09-26
US4419348A (en) 1983-12-06
EP0077377B1 (de) 1986-01-08
DK163277B (da) 1992-02-17
DE3268367D1 (en) 1986-02-20
EP0077377A1 (de) 1983-04-27
AU8520982A (en) 1982-11-24
AU552812B2 (en) 1986-06-19
DK573082A (da) 1982-12-23
WO1982003769A1 (en) 1982-11-11

Similar Documents

Publication Publication Date Title
DK163277C (da) Anthracyklinglycosid-kardiolipinkompleks indkapslet i liposomer, fremgangsmaade til fremstilling heraf samt terapeutisk praeparat indeholdende dette
DK87881A (da) Piperidinderivater samt fremgangsmaade til fremstilling deraf
DK328083D0 (da) Opvaskemiddel samt fremgangsmade til fremstilling deraf
NO793885L (no) Flytende dentalperparat, samt fremgangsmaate for fremstilling derav.
DK165361C (da) Praeparater med indkapslede partikler samt fremgangsmaade til fremstilling deraf
DK510384D0 (da) Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf
DK273587D0 (da) 1,5-diaryl-3-substituerede pyrazoler samt fremgangsmaade til fremstilling deraf
DK74087A (da) Indolizinderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
DK186981A (da) 17-substitueret-6-desoxy-7,8-dihydro-6alfa-methylnoroxymorphon samt fremgangsmaade til fremstilling deraf
DK307883D0 (da) Carbostyrilderivater samt fremgangsmade til fremstilling deraf
NZ190923A (en) Platinum diamine complexes medical preparations
DK54382A (da) 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridiner samt fremgangsmaade til fremstilling deraf
DK181983D0 (da) 1,8-naphthyridin- og 1,5,8-azanaphthyridin-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK93383A (da) Glycoproteiner samt fremgangsmaade til fremstilling heraf
PH19245A (en) Pharmaceutical preparations
DK409784A (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
DK64183A (da) Farmaceutisk praeparat samt fremgangsmaade til fremstilling deraf
DK426083A (da) Pteriner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK418684A (da) Farmaceutiske midler indeholdende pyridazinonderivater, fremgangsmaade til fremstilling heraf samt mellemprodukter derfor
NO790917L (no) N-oksacyklyl-alkyl-piperidin, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser, samt deres terapeutiske anvendelse
DK114584A (da) Fast farmaceutisk praeparat samt fremgangsmaade til fremstilling deraf
DK364483D0 (da) 14-aminosteroid-derivater samt fremgangsmade til fremstilling deraf
DK160885A (da) Benzazepinderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse
SG43384G (en) Pharmaceutical preparations
JPS5660577A (en) Protein bubble fireeextinguishing substance